X
Record #65799

TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types

Original paper date
Aug 31, 2019
Institution
Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA · Gynecologic Cancer Center of Excellence, John P. Murtha Cancer Center, Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD, USA · John P. Murtha Cancer Center, Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD, USA · Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL, USA · Department of Obstetrics and Gynecology, Inova Fairfax Hospital, Falls Church, VA, USA · Inova Schar Cancer Institute, Inova Center for Personalized Health, Falls Church, VA, USA · Department of Molecular and Cell Biology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Open access
No
Article type
Research Article
Broad categories
(BLS) Biology - Cancer(BLS) Biology - Cellular(BLS) Genetics(HSC) Medicine - Obstetrics/Gynecology
Citation lifecycle

How this paper is being cited

Pre-retraction
9
Same day
0
Post-retraction
1
% post-retraction
10.0%
~1.6 citations/yr before retraction · ~0.8 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse